A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Heparin
Barnidipine
The serum concentration of Pretomanid can be increased when it is combined with Barnidipine.
Heparin
Netupitant
The serum concentration of Pretomanid can be increased when it is combined with Netupitant.
Heparin
Indalpine
The serum concentration of Pretomanid can be increased when it is combined with Indalpine.
Heparin
Luliconazole
The serum concentration of Pretomanid can be increased when it is combined with Luliconazole.
Heparin
Linagliptin
The serum concentration of Pretomanid can be increased when it is combined with Linagliptin.
Heparin
Crizotinib
The serum concentration of Pretomanid can be increased when it is combined with Crizotinib.
Heparin
Seproxetine
The serum concentration of Pretomanid can be increased when it is combined with Seproxetine.
Heparin
Nilvadipine
The serum concentration of Pretomanid can be increased when it is combined with Nilvadipine.
Heparin
Desvenlafaxine
The serum concentration of Pretomanid can be increased when it is combined with Desvenlafaxine.
Heparin
Isavuconazonium
The serum concentration of Pretomanid can be increased when it is combined with Isavuconazonium.
Heparin
Simeprevir
The serum concentration of Pretomanid can be increased when it is combined with Simeprevir.
Heparin
Milnacipran
The serum concentration of Pretomanid can be increased when it is combined with Milnacipran.
Heparin
Danazol
The serum concentration of Pretomanid can be increased when it is combined with Danazol.
Heparin
Metreleptin
The metabolism of Pretomanid can be increased when combined with Metreleptin.
Heparin
Pitolisant
The serum concentration of Pretomanid can be decreased when it is combined with Pitolisant.
Trilostane
Satralizumab
The serum concentration of Indacaterol can be decreased when it is combined with Satralizumab.
Trilostane
Abametapir
The serum concentration of Indacaterol can be increased when it is combined with Abametapir.
Trilostane
Tucatinib
Indacaterol may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Trilostane
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Indacaterol.
Trilostane
Cenobamate
The serum concentration of Indacaterol can be decreased when it is combined with Cenobamate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3